Senores Pharmaceuticals Other Announcement

Senores Pharmaceuticals Other Announcement

Senores Pharmaceuticals reported no deviation in utilising the Rs 95 Crore raised via a preferential warrant issue for the quarter ended September 30, 2026. Audit Committee reviewed the statement and the Board took it on record.

Value

₹95.00 Cr

Senores Pharmaceuticals Capacity Expansion: ₹20 Cr Investment

Senores Pharmaceuticals' subsidiary Apnar Pharma Private Limited plans a 0.7 Bn unit capacity addition by March 2027. The investment is Rs.20.00 Crore, funded by internal accruals and IPO proceeds.

Value

₹20.00 Cr

Execution

By end of March 2027

production capacity

0.7 Bn units

Senores Pharmaceuticals Capacity Expansion: ₹18 Cr Investment

Senores Pharmaceuticals plans to add 0.8 Bn units of capacity to its existing 1.2 Bn unit plant by March 2027. The investment is Rs.18.00 Crore, funded by internal accruals and IPO proceeds.

Value

₹18.00 Cr

Execution

By end of March 2027

production capacity

0.8 Bn units

Senores Pharmaceuticals Investor Presentation: Key Takeaways

Q2 FY27 revenue ₹192.3 Cr (+24.9%), EBITDA ₹57.7 Cr (+38.3%, 30.0% margin), PAT ₹36.6 Cr. H1 revenue +30%, EBITDA +58.2%.

Senores Pharmaceuticals Results Update

Senores reported Q2 FY27 revenue of ₹192 cr and EBITDA of ₹58 cr, both record highs. PAT grew 22% Y-o-Y to ₹37 cr with positive FY27 outlook.

Senores Pharmaceuticals Capacity Expansion: ₹43 Cr Investment

Senores Pharmaceuticals disclosed capacity expansion at three subsidiaries with total estimated cost of ₹43 Crore. Expansions adding ~1.5 Bn units/annum are expected by March 2027.

Value

₹43.00 Cr

Execution

By end of March 2027

manufacturing capacity addition (per annum)

1502.7 Mn units

Pine Labs Other Announcement

Pine Labs Limited filed CARE Ratings' Monitoring Agency Report for the quarter ended September 30, 2026, on its IPO proceeds. The report shows no deviation from objects and no major deviations.

Sihora Industries Other Announcement

Sihora Industries reported IPO proceeds utilisation of Rs.983.87 lakh of Rs.1,056 lakh raised, to September 2026. Shareholders approved the object deviation on 17 August 2026.

Titan Company Other Announcement

Titan's employee stock option trust transferred 19,385 shares worth Rs.8.40 Crore to eligible employees after PSU exercise. The off-market transfer was disclosed under PIT Reg 7(2).

Value

₹8.40 Cr

Hindustan Petroleum Corporation Other Announcement

HPCL filed its quarterly share capital reconciliation audit certificate for the quarter ended September 30, 2026. It confirms 212.85 crore issued shares, matching listed and depository records.

KRN Heat Exchanger and Refrigeration Other Announcement

KRN Heat Exchanger filed its Reg 32 statement confirming no deviation in QIP fund use, with INR 349.99 Crore raised on 1 June 2026. The utilisation table reports no variation across the three objects.

NIIT Learning Systems Other Announcement

NIIT Learning Systems board recommended appointing Price Waterhouse Chartered Accountants LLP as statutory auditor for five years from the 25th AGM. The incumbent S. R. Batliboi firm completes its second term.

Execution

Five consecutive years, from the 25th AGM (2027) until the 30th AGM (2032)